The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients

• Status: Unknown status
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The proposed study is a pilot study and a first step towards developing an optimized HPV vaccination strategy for girls who have CKD, or are on dialysis or have a kidney transplant.

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Indiana University
• Collaborators: Merck Sharp & Dohme Corp.; National Kidney Foundation
• Treatments: Vaccines

Criteria

Inclusion Criteria:

• 9-18-year-old girls who have CKD stages 3 or 4 (Glomerular filtration rates 15-59 mL/min/1.73m2).

• 9-18-year-old girls who are on dialysis.

• 9-18-year-old girls who have had a functioning kidney transplant for longer than 6 months and are on the same immunosuppression regimen.

• Healthy 9-18-year-old girls

Exclusion Criteria:

• Pregnancy, fever, allergy to any vaccine component, any immune disorder and any blood product received in the previous 6 months.